Jay Cross
Finanzdirektor/CFO bei SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Vermögen: 1 913 $ am 30.04.2024
Profil
John Harry Cross is currently the Chief Financial & Business Officer at Sonnet BioTherapeutics, Inc. and Sonnet BioTherapeutics Holdings, Inc. He previously worked as the Managing Director-Healthcare Investment Banking at Chardan Capital Markets LLC and as a Director at Alere Financial Partners.
He received his undergraduate degree from Washington & Lee University and his graduate degree from Yale School of Medicine.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
11.12.2023 | 1 087 ( 0,04% ) | 1 913 $ | 30.04.2024 |
Aktive Positionen von Jay Cross
Unternehmen | Position | Beginn |
---|---|---|
SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Finanzdirektor/CFO | 01.05.2019 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Finanzdirektor/CFO | 01.05.2019 |
Ehemalige bekannte Positionen von Jay Cross
Unternehmen | Position | Ende |
---|---|---|
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Corporate Officer/Principal | 01.03.2019 |
Alere Financial Partners
Alere Financial Partners Investment ManagersFinance Alere Financial Partners provides investment research. The private company is based in King of Prussia, PA. | Direktor/Vorstandsmitglied | 01.06.2015 |
Ausbildung von Jay Cross
Yale School of Medicine | Graduate Degree |
Washington & Lee University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Health Technology |
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Finance |
Alere Financial Partners
Alere Financial Partners Investment ManagersFinance Alere Financial Partners provides investment research. The private company is based in King of Prussia, PA. | Finance |